Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Tipo de estudo
Intervalo de ano de publicação
1.
Georgian Med News ; (349): 54-59, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38963202

RESUMO

Doxorubicin is the common chemotherapeutic agent that has been harnessed for the treatment of various types of malignancy including the treatment of soft tissue and osteosarcoma and cancers of the vital organs like breast, ovary, bladder, and thyroid. It is also used to treat leukaemia and lymphoma, however, this is an obstacle because of their prominent side effects including cardiotoxicity and lung fibrosis, we do aim to determine the role of CoQ10 as an antioxidant on the impeding the deleterious impacts of doxorubicin on tissue degenerative effects. To do so, 27 rats were subdivided into 3 groups of 9 each; CoQ10 exposed group, Doxorubicin exposed group, and CoQ10 plus Doxorubicin group. At the end of the study, the animals were sacrificed and lungs with hearts were harvested, and slides were prepared for examination under a microscope. The results indicated that doxorubicin induced abnormal cellular structure resulting in damaging cellular structures of the lung and heart while CoQ10 impeded these damaging effects and nearly restoring normal tissue structure. As a result, CoQ10 will maintain normal tissue of the lung and heart.


Assuntos
Doxorrubicina , Pulmão , Ubiquinona , Animais , Doxorrubicina/efeitos adversos , Ubiquinona/análogos & derivados , Ubiquinona/farmacologia , Ratos , Pulmão/efeitos dos fármacos , Pulmão/patologia , Antibióticos Antineoplásicos/efeitos adversos , Antibióticos Antineoplásicos/toxicidade , Miocárdio/patologia , Masculino , Antioxidantes/farmacologia , Cardiotoxicidade/etiologia , Cardiotoxicidade/patologia , Coração/efeitos dos fármacos
2.
Pathogens ; 12(2)2023 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-36839600

RESUMO

BACKGROUND: Accurate mortality data associated with infectious diseases such as coronavirus disease 2019 (COVID-19) are often unavailable in countries with fragile health systems such as Somalia. We compared officially reported COVID-19 deaths in Somalia with COVID-19 deaths estimated using verbal autopsy. METHODS: We interviewed relatives of deceased persons to collect information on symptoms, cause, and place of death. We compared these data with officially reported data and estimated the positive and negative predictive values of verbal autopsy. RESULTS: We identified 530 deaths during March-October 2020. We classified 176 (33.2%) as probable COVID-19 deaths. Most deaths (78.5%; 416/530) occurred at home and 144 (34.6%) of these were attributed to COVID-19. The positive predictive value of verbal autopsy was lower for home deaths (22.3%; 95% CI: 15.7-30.1%) than for hospital deaths (32.3%; 95% CI: 16.7-51.4%). The negative predictive value was higher: 97.8% (95% CI: 95.0-99.3%) for home deaths and 98.4% (95% CI: 91.5-100%) for hospital deaths. Conclusions Verbal autopsy has acceptable predictive value to estimate COVID-19 deaths where disease prevalence is high and can provide data on the COVID-19 burden in countries with low testing and weak mortality surveillance where home deaths may be missed.

3.
(East. Mediterr. health j).
em Inglês | WHO IRIS | ID: who-116922

RESUMO

To measure asthma prevalence and severity among children in Baghdad, we randomly sampled 3360 primary-school children and had their parents complete st and ardized questionnaires. The response rate was 86%, male to female ratio was 0.75:1 and age range was 6-12 years. Prevalence of wheezing ever was 25.0%. Wheezing during the last 12 months was 19.9% and 2.9% of the children had more than 12 attacks. Parents reported nocturnal wheezing for 16.3% of the children and severe attacks that limited speech for 10.5%. Prevalence of asthma ever was 22.3%. Asthma was detected in 81.9% of those with wheezing in the last 12 months. Males were predominant among children with wheezing ever, whereas females were predominant among children with asthma ever. Prevalence rates of asthma and of severe asthma symptoms decreased with increasing age


Assuntos
Distribuição por Idade , Estudos Transversais , Inquéritos Epidemiológicos , Distribuição por Sexo , Asma
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...